Literature DB >> 18802017

Liver X receptor activation induces the uptake of cholesteryl esters from high density lipoproteins in primary human macrophages.

Stephanie Bultel1, Lionel Helin, Veronique Clavey, Giulia Chinetti-Gbaguidi, Elena Rigamonti, Morvane Colin, Jean-Charles Fruchart, Bart Staels, Sophie Lestavel.   

Abstract

OBJECTIVE: Liver X receptors (LXRs) are oxysterol-activated nuclear receptors regulating reverse cholesterol transport, in part by modulating cholesterol efflux from macrophages to apoAI and HDL via the ABCA1 and ABCG1/ABCG4 pathways. Moreover, LXR activation increases intracellular cholesterol trafficking via the induction of NPC1 and NPC2 expression. However, implication of LXRs in the selective uptake of cholesteryl esters from lipoproteins in human macrophages has never been reported. METHODS AND
RESULTS: Our results show that (1) selective CE uptake from HDL(3) is highly efficient in human monocyte-derived macrophages; (2) surprisingly, HDL(3)-CE uptake is strongly increased by LXR activation despite antiatherogenic effects of LXRs; (3) HDL(3)-CE uptake increase is not linked to SR-BI expression modulation but it is dependent of proteoglycan interactions; (4) HDL(3)-CE uptake increase is associated with increased expression and secretion of apoE and LPL, two proteins interacting with proteoglycans; (5) HDL(3)-CE uptake increase depends on the integrity of raft domains and is associated with an increased caveolin-1 expression.
CONCLUSIONS: Our study identifies a new role for LXRs in the control of cholesterol homeostasis in human macrophages. LXR activation results in enhanced dynamic intracellular cholesterol fluxes through an increased CE uptake from HDL and leads to an increased cholesterol availability to efflux to apoAI and HDL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802017     DOI: 10.1161/ATVBAHA.108.175042

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

Review 1.  Liver X receptors, atherosclerosis and inflammation.

Authors:  Daryn R Michael; Tim G Ashlin; Melanie L Buckley; Dipak P Ramji
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

Review 2.  Role of the steroidogenic acute regulatory protein in health and disease.

Authors:  Pulak R Manna; Cloyce L Stetson; Andrzej T Slominski; Kevin Pruitt
Journal:  Endocrine       Date:  2015-08-14       Impact factor: 3.633

Review 3.  Lipid homeostasis and the formation of macrophage-derived foam cells in atherosclerosis.

Authors:  Yuan Yuan; Peng Li; Jing Ye
Journal:  Protein Cell       Date:  2012-03-23       Impact factor: 14.870

Review 4.  Monocyte and macrophage dynamics during atherogenesis.

Authors:  Klaus Ley; Yury I Miller; Catherine C Hedrick
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07       Impact factor: 8.311

5.  Scavenger receptor SR-BI in macrophage lipid metabolism.

Authors:  Ailing Ji; Jason M Meyer; Lei Cai; Akinwunmi Akinmusire; Maria C de Beer; Nancy R Webb; Deneys R van der Westhuyzen
Journal:  Atherosclerosis       Date:  2011-04-09       Impact factor: 5.162

6.  High-density lipoprotein therapy: is there hope?

Authors:  Kunal N Bhatt; Bryan J Wells; Laurence S Sperling; Jefferson T Baer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-08

Review 7.  Update on strategies to increase HDL quantity and function.

Authors:  Danielle Duffy; Daniel J Rader
Journal:  Nat Rev Cardiol       Date:  2009-06-02       Impact factor: 32.419

8.  Chronic Activation of Liver X Receptor Sensitizes Mice to High Cholesterol Diet-Induced Gut Toxicity.

Authors:  Wojciech G Garbacz; Hirdesh Uppal; Jiong Yan; Meishu Xu; Songrong Ren; Donna B Stolz; Min Huang; Wen Xie
Journal:  Mol Pharmacol       Date:  2018-07-25       Impact factor: 4.436

Review 9.  Liver X receptors at the intersection of lipid metabolism and atherogenesis.

Authors:  Stephen D Lee; Peter Tontonoz
Journal:  Atherosclerosis       Date:  2015-07-02       Impact factor: 5.162

10.  Caveolin-1-mediated apolipoprotein A-I membrane binding sites are not required for cholesterol efflux.

Authors:  Soazig Le Lay; Macarena Rodriguez; Wendy Jessup; Carles Rentero; Qiong Li; Siân Cartland; Thomas Grewal; Katharina Gaus
Journal:  PLoS One       Date:  2011-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.